Page 2 - Catalyst Flex News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Calyx Welcomes Catalyst to the ACTIVATE CRO Partnership Program
Synergistic offerings deliver successful early-phase oncology clinical trials.
News provided by
Share this article
Share this article
NOTTINGHAM, England, May 10, 2021 /PRNewswire/  Calyx, the eClinical and Regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced that Catalyst Clinical Research will enter into a partnership with Calyx to leverage Calyx s Medical Imaging solution for their customers oncology trials.
John Blakeley, Chief Commercial Officer, Calyx
Calyx s proven imaging services complement Catalyst s expertise in executing complex oncology trials for biotech clients
A leading provider of clinical research services, Catalyst Clinical Research s full-service, niche oncology CRO solution is focused on next-generation cancer therapies. Catalyst Oncology offers skilled management of immuno-oncology a ....

John Blakeley , Andrew Zupnick , Catalyst Clinical Research , Novaquest Capital Management , Oncology Drug Development At Catalyst , Catalyst Oncology , Vice President , Oncology Drug Development , Chief Commercial Officer , Medical Imaging , Clinical Research , Catalyst Flex , ஜான் பிளேக்லி , வினையூக்கி மருத்துவ ஆராய்ச்சி , துணை ப்ரெஸிடெஂட் , புற்றுநோயியல் மருந்து வளர்ச்சி , தலைமை வணிகரீதியானது அதிகாரி , மருத்துவ இமேஜிங் , மருத்துவ ஆராய்ச்சி ,